March 17, 2025 Bayer welcomes new law in U.S. state to better shield it against glyphosate litigation Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of ...

At least eight agencies are investigating a recent fire at a Bayer executive’s New Jersey home as a possible arson, authorities said.The fire happened around 7:30 a.m. March 4 “at an occupied ...

PARSIPPANY, N.J. — Multiple federal and state agencies are investigating a possible arson attempt at the New Jersey home of an executive of global pharmaceutical giant Bayer, authorities said.

Yesterday I broke the news that the CDC has indefinitely shuttered the Pregnancy Risk Assessment Monitoring System (PRAMS), a ...

In a statement, Bayer said that after reviewing the data for eliapixant (formerly BAY1817080 ) it had concluded that "the overall benefit no long outweighs the risk" in the drug's four target ...

Cash call worth about $9 billion based on current value Company says would only use the extra capital if essential Bayer has paid $10 billion on Roundup settlements Share price falls more than 6% ...

At least eight agencies are investigating the cause of a fire at the New Jersey home of a Bayer pharmaceutical executive this month. The fire was reported around 7:30 a.m. March 4 and "quickly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Big Group Hug (BGH) needs your help and needs your previously loved prams. The group, which operates out of Tarneit and Thomastown, has experienced a continued rise in community members requesting aid ...

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...